Low Level Laser Device Manufacturer
Based in Australia, RianCorp focuses on medical laser products and manufactures devices for low level laser therapy (LLLT).
Their LTU-904 low level laser device offers a painless and effective solution for the treatment of post-mastectomy lymphedema. The LTU-904 laser is the only laser device that has been cleared by the FDA for lymphedema treatment after breast cancer.
This lightweight, handheld infra-red, low level laser operates at a wavelength of 904 nanometers. Classified by the FDA as a Class 1 laser, protective eyewear isn’t required for patients or therapists when the laser is in use.
In a randomized, double-blind clinical trial, RianCorp tested the effects of LLLT on lymphedema – the clinical trial was the first of its kind in the world!
The study showed that the benefits of laser therapy treatment for post-mastectomy lymphedema include:
- reduced arm volume and extra-cellular fluid in the arm
- less inflammation and swelling
- shorter recovery times
- reduced scar tissue and scarring.